Activity Details

Free CME
0.25 AMA PRA Category 1 Credit(s)
Released: October 19, 2020
Expires: October 18, 2021
15 minutes to complete

Accredited By

Target Audience

Pulmonologists, primary care providers, and other health care providers who manage patients with ILD.

Learning Objectives


  • Integrate new information on IPF treatment into practice as it becomes available
  • Recognize the side effects associated with antifibrotic use


  • Diagnose SSc-ILD based on clinical impression and appropriate diagnostic tests
  • Evaluate therapeutic options for the management of SSc-ILD in terms of efficacy and safety


  • Identify the ILDs most commonly associated with a progressive fibrosing phenotype (PF-ILD)
  • Describe the signs and symptoms associated with PF-ILD
  • Describe the clinical course of a PF-ILD
  • Review the general therapeutic options available for the management of PF-ILDs

Activity Description

Video reports on posters and sessions from the virtual ERS 2020 congress. Faculty discuss the latest clinical trial and real world data on IPF, systemic sclerosis-ILD, and progressive fibrosing-ILD. They also discuss the implications of this information for current clinical practices.


Vikramjit Khangoora, MD
Inova Fairfax Hospital
Fairfax, Virginia

Maria Molina, MD, PhD
Laboratory Manager/ILD Unit Coordinator
Idibell Bellvitge Biomedical Research Institute
Barcelona, Spain

Luca Richeldi, MD, PhD
Head, Division of Respiratory Disease
Gemelli University Hospital
Rome, Italy

Ganesh Raghu, MD, FCCP, FACP
Professor of Medicine, Division of Pulmonary, Sleep & Critical Care Medicine
Adjunct Professor of Laboratory Medicine and Pathology
University of Washington
Director, Center for Interstitial Lung Disease, ILD, Sarcoid and Pulmonary Fibrosis Program
Co-Director, Scleroderma Clinic
UW Medical Center
Seattle, Washington

Conflict of Interest Policy/Disclosure Statement

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

The following faculty report that they have no relevant financial relationships to disclose:

  • Vikramjit Khangoora, MD

The following faculty report that they have relevant financial relationships to disclose:

  • Maria Molina, MD, PhD, has received honoraria or grants for participation in scientific activities from Boehringer Ingelheim Pharmaceuticals, Inc.
  • Luca Richeldi, MD, PhD, has participated in contract research for Boehringer Ingelheim Pharmaceuticals, Inc., and Roche. He has also served as a consultant for Boehringer Ingelheim Pharmaceuticals, Inc., Fibrogen, Nitto, and Roche.
  • Ganesh Raghu, MD, has served as a consultant for Bellerophan, Biogen, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers Squibb, Fibrogen, Genentech, Gilead, Nitto, Patara, Promedior, Sanofi, UCB, and Veracyte.

Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The France Foundation designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider.

Method of Participation/How to Receive Credit

  • There are no fees for participating in and receiving credit for this activity.
  • Review the activity objectives and CME/CE information.
  • Complete the CME/CE activity.
  • Complete the online posttest. A score of 100% is required to successfully complete this activity. The participant may take the test until successfully passed.
  • Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  • Credit documentation/reporting:
    • If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.

Statement of Commercial Support

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Disclaimer Statement/Disclosure of Unlabeled Use

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Contact Information for Questions about the Activity

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.